Pulmonary Function Testing Systems Market Trends

Pulmonary Function Testing Systems Market Trends

Increasing incidence of patients suffering from chronic respiratory diseases will primarily drive the market share. Chronic respiratory diseases are one of the leading causes of death across the globe. The disease progression is marked by recurring exacerbations and a steady loss in patients' functional level, culminating in a significant socioeconomic burden. This incremental rise in patient population has substantially increased the hospitalization rate, thereby augmenting the demand for diagnostic products.
 

The clinical advantages associated with pulmonary function testing systems has increased the product adoption in several healthcare facilities. Diseases such as asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD), and other occupational lung diseases are some of the diseases that are contributing to the augmenting market revenue. According to the U.S. Department of Health & Human Services and CDC data, in 2020, around 15 million Americans were suffering from chronic obstructive pulmonary disease and is anticipated to increase during the estimated timeframe. The rising number of COPD cases is attributed to the risk factors such as smoking and indoor & outdoor air quality.